Selective TASK-1 Inhibitor with a Defined Structure-Activity Relationship Reduces Cancer Cell Proliferation and Viability.
Bárbara ArévaloMauricio BedoyaAytuğ K KiperFernando VergaraDavid RamírezYuliet MazolaDaniel BustosRafael ZúñigaRocio CikutovicAngel CayoSusanne RinnéM Teresa Ramirez-ApanFrancisco V SepúlvedaOscar CerdaEduardo López-CollazoNiels DecherLeandro ZúñigaMargarita GutierrezWendy GonzálezPublished in: Journal of medicinal chemistry (2022)
Chemical structures of selective blockers of TASK channels contain aromatic groups and amide bonds. Using this rationale, we designed and synthesized a series of compounds based on 3-benzamidobenzoic acid. These compounds block TASK-1 channels by binding to the central cavity. The most active compound is 3-benzoylamino -N -(2-ethyl-phenyl)-benzamide or F3 , blocking TASK-1 with an IC 50 of 148 nM, showing a reduced inhibition of TASK-3 channels and not a significant effect on different K + channels. We identified putative F3-binding sites in the TASK-1 channel by molecular modeling studies. Mutation of seven residues to A (I118A, L122A, F125A, Q126A, L232A, I235A, and L239A) markedly decreased the F3-induced inhibition of TASK-1 channels, consistent with the molecular modeling predictions. F3 blocks cell proliferation and viability in the MCF-7 cancer cell line but not in TASK-1 knockdown MCF-7 cells, indicating that it is acting in TASK-1 channels. These results indicated that TASK-1 is necessary to drive proliferation in the MCF-7 cancer cell line.